$20.47
1.22[6.34%]
Last update: 9:47AM Get Real Time Here
Cullinan Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cullinan Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | PM | CGEM | Q1 | -$1.42 | -$0.95 | — | — | $0.00 | — | — | — | Get Alert |
03/14/2024 | AM | CGEM | Q4 | -$0.91 | -$0.96 | -$0.54 | 43.75% | $0.00 | — | $0.00 | — | Get Alert |
11/08/2023 | AM | CGEM | Q3 | -$0.82 | -$0.92 | -$0.91 | 1.09% | $0.00 | — | $0.00 | — | Get Alert |
08/10/2023 | AM | CGEM | Q2 | $3.77 | -$0.97 | -$0.82 | 15.46% | $0.00 | — | $0.00 | — | Get Alert |
05/11/2023 | PM | CGEM | Q1 | -$0.27 | -$0.98 | -$1.42 | -44.90% | $0.00 | — | $0.00 | — | Get Alert |
03/09/2023 | AM | CGEM | Q4 | -$0.74 | -$0.66 | -$0.59 | 10.61% | $0.00 | — | $0.00 | — | Get Alert |
11/14/2022 | AM | CGEM | Q3 | -$0.40 | — | -$0.54 | — | $0.00 | — | $0.00 | — | Get Alert |
08/10/2022 | AM | CGEM | Q2 | -$0.27 | — | $3.77 | — | $0.00 | — | $0.00 | — | Get Alert |
05/16/2022 | AM | CGEM | Q1 | $0.00 | — | -$0.27 | — | $18.94M | — | $0.00 | — | Get Alert |
03/17/2022 | AM | CGEM | Q4 | -$1.39 | -$0.47 | -$0.74 | -57.45% | $0.00 | — | $0.00 | — | Get Alert |
11/09/2021 | AM | CGEM | Q3 | -$0.50 | -$0.48 | -$0.40 | 16.67% | $0.00 | — | $0.00 | — | Get Alert |
08/10/2021 | AM | CGEM | Q2 | -$0.44 | -$0.41 | -$0.36 | 12.20% | $0.00 | — | $0.00 | — | Get Alert |
05/14/2021 | AM | CGEM | Q1 | -$0.27 | -$0.38 | $0.00 | 100.00% | — | — | $18.94M | — | Get Alert |
03/30/2021 | AM | CGEM | FY | — | — | -$5.48 | — | — | — | $0.00 | — | Get Alert |
Cullinan Therapeutics (CGEM) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 14, 2024 for Q4.
The Actual EPS was $-0.54, which beat the estimate of $-0.96.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.